Clinical Trial Update: Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating risperidone and olanzapine in schizophrenic patients with neuroleptic-induced tardive dyskinesia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tardive Dyskinesia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• olanzapine (olanzapine)

Snippet

Sponsor: Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan | Conditions: Neuroleptic-Induced Tardive Dyskinesia | Phase 4 | Status: COMPLETED